These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Pathogenesis of hypercalcemia associated with malignant tumors]. François D; Body JJ; Nijs-De Wolf N; Fuss M; Gillet C; Corvilain J Rev Med Brux; 1987; 8(6-7):359-62. PubMed ID: 2823362 [No Abstract] [Full Text] [Related]
4. [Mechanisms of significance in the development of hypercalcemia in malignant disease]. Kristensen B; Holmegaard SN; Frølich A; Transbøl I Ugeskr Laeger; 1985 Mar; 147(11):935-8. PubMed ID: 3992688 [No Abstract] [Full Text] [Related]
5. [Hypercalcemia and neoplasms]. Rossetti A; Taliani U; Pioli G; Sansoni P G Clin Med; 1987; 68(6-7):335-8, 340-5. PubMed ID: 2888700 [No Abstract] [Full Text] [Related]
6. [Hypercalcemic bone metastases of malignant melanoma]. Garcier F; Claudy AL; Tolot O; Chappard D; Riffat G Ann Dermatol Venereol; 1984; 111(6-7):589-92. PubMed ID: 6497255 [No Abstract] [Full Text] [Related]
7. Contribution of parathyroid hormone-related peptide to the evaluation of hypercalcemia. Audran M; Minebois-Villégas A; Lortholary A; Legrand E; Pascaretti C; Giraud P; Subra JF; Boasson M; Jallet P Rev Rhum Engl Ed; 1995 Mar; 62(3):189-96. PubMed ID: 7788336 [TBL] [Abstract][Full Text] [Related]
8. The multiple causes of hypercalcemia in malignant disease. Sherwood LM N Engl J Med; 1980 Dec; 303(24):1412-3. PubMed ID: 6253787 [No Abstract] [Full Text] [Related]
9. [Results of using Aredia for hypercalcemia in oncology patients]. Lichinitser MR; Vyshinskaia GV; Kupchan DZ; Liubimova NV Ter Arkh; 1993; 65(9):80-1. PubMed ID: 8303606 [No Abstract] [Full Text] [Related]
10. Hypercalcemia of malignancy: pathophysiology and implications for treatment. Theriault RL Oncology (Williston Park); 1993 Jan; 7(1):47-50; discussion 52-5. PubMed ID: 8420542 [TBL] [Abstract][Full Text] [Related]
12. [Hypercalcemia and vital prognosis of cancers with bone metastases]. Crouzet J; Juan LH; Guillien P Rev Rhum Mal Osteoartic; 1990 Jan; 57(1):1-3. PubMed ID: 2320922 [No Abstract] [Full Text] [Related]
13. [Performances of two kits for parathyroid hormone-related peptide (PTHrP) assay in the additional study of malignant hypercalcemias]. Minebois-Villegas A; Audran M; Lortholary A; Legrand E; Boux De Casson-Raimbeau F; Jallet P Pathol Biol (Paris); 1995 Nov; 43(9):799-805. PubMed ID: 8746102 [TBL] [Abstract][Full Text] [Related]
14. [Hypercalcemia associated with malignant neoplastic disorders: attempt at physiopathologic interpretation. 15 cases]. Bloch-Michel H; Aristoff H; Gorins A; Dussart N Rev Rhum Mal Osteoartic; 1969 Apr; 36(4):174-90. PubMed ID: 5402944 [No Abstract] [Full Text] [Related]
15. [Bisphosphonates. Drugs for the treatment of disorders of calcium and bone metabolism]. Warneke G; Henning HV Internist (Berl); 1992 Jun; 33(6):441-5. PubMed ID: 1385800 [No Abstract] [Full Text] [Related]
16. Biochemical evaluation of patients with cancer-associated hypercalcemia: evidence for humoral and nonhumoral groups. Stewart AF; Horst R; Deftos LJ; Cadman EC; Lang R; Broadus AE N Engl J Med; 1980 Dec; 303(24):1377-83. PubMed ID: 6253785 [TBL] [Abstract][Full Text] [Related]
17. [Hypercalcemia and skeletal engagement in malignancy--development and therapeutic possibilities]. Ljunghall S; Bergh J; Rastad J; Akerström G Lakartidningen; 1989 May; 86(21):1991-3. PubMed ID: 2733514 [No Abstract] [Full Text] [Related]
18. [Differential diagnosis and therapy of tumor-associated hypercalcemia]. Thomas M; Schneider W Dtsch Med Wochenschr; 1989 Oct; 114(41):1576-81. PubMed ID: 2680409 [No Abstract] [Full Text] [Related]
19. [Hypercalcemia of cancer and myeloma]. Lemaire V Rev Rhum Mal Osteoartic; 1984 Dec; 51(11):633-42. PubMed ID: 6395303 [TBL] [Abstract][Full Text] [Related]
20. [Endocrinological examination of malignant tumors. Hypercalcemia in malignant tumors]. Abe K Rinsho Byori; 1974 Oct; 22(10 Suppl):28. PubMed ID: 4475870 [No Abstract] [Full Text] [Related] [Next] [New Search]